Cargando…

High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort

BACKGROUND: Recent studies have demonstrated the association between increased concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and the incidence of myocardial infarction, heart failure, and mortality. However, most prognostic studies to date focus on the value of hs-cTnT in the elder...

Descripción completa

Detalles Bibliográficos
Autores principales: Mingels, Alma M., Joosen, Ivo A., Versteylen, Mathijs O., Laufer, Eduard M., Winkens, Mark H., Wildberger, Joachim E., Van Dieijen-Visser, Marja P., Hofstra, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338816/
https://www.ncbi.nlm.nih.gov/pubmed/22558116
http://dx.doi.org/10.1371/journal.pone.0035059
_version_ 1782231270678331392
author Mingels, Alma M.
Joosen, Ivo A.
Versteylen, Mathijs O.
Laufer, Eduard M.
Winkens, Mark H.
Wildberger, Joachim E.
Van Dieijen-Visser, Marja P.
Hofstra, Leonard
author_facet Mingels, Alma M.
Joosen, Ivo A.
Versteylen, Mathijs O.
Laufer, Eduard M.
Winkens, Mark H.
Wildberger, Joachim E.
Van Dieijen-Visser, Marja P.
Hofstra, Leonard
author_sort Mingels, Alma M.
collection PubMed
description BACKGROUND: Recent studies have demonstrated the association between increased concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and the incidence of myocardial infarction, heart failure, and mortality. However, most prognostic studies to date focus on the value of hs-cTnT in the elderly or general population. The value of hs-cTnT in symptomatic patients visiting the outpatient department remains unclear. The aim of this study was to investigate the prognostic value of hs-cTnT as a biomarker in patients with symptoms of chest discomfort suspected for coronary artery disease and to assess its additional value in combination with other risk stratification tools in predicting cardiac events. METHODS: We studied 1,088 patients (follow-up 2.2±0.8 years) with chest discomfort who underwent coronary calcium scoring and coronary CT-angiography. Traditional cardiovascular risk factors and concentrations of hs-cTnT, N-terminal pro-brain-type natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hsCRP) were assessed. Study endpoint was the occurrence of late coronary revascularization (>90 days), acute coronary syndrome, and cardiac mortality. RESULTS: Hs-cTnT was a significant predictor for the composite endpoint (highest quartile [Q4]>6.7 ng/L, HR 3.55; 95%CI 1.88–6.70; P<0.001). Survival analysis showed that hs-cTnT had significant predictive value on top of current risk stratification tools (Chi-square change P<0.01). In patients with hs-cTnT in Q4 versus <Q4, a 2- to 3-fold increase in cardiovascular risk was noticed, either when corrected for high or low Framingham risk score, coronary calcium scoring, or CT-angiography assessment (HR 3.11; 2.73; 2.47; respectively; all P<0.01). This was not the case for hsCRP and NT-proBNP. CONCLUSIONS: Hs-cTnT is a useful prognostic biomarker in patients with chest discomfort suspected for coronary artery disease. In addition, hs-cTnT was an independent predictor for cardiac events when corrected for cardiovascular risk profiling, calcium score and CT-angiography results.
format Online
Article
Text
id pubmed-3338816
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33388162012-05-03 High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort Mingels, Alma M. Joosen, Ivo A. Versteylen, Mathijs O. Laufer, Eduard M. Winkens, Mark H. Wildberger, Joachim E. Van Dieijen-Visser, Marja P. Hofstra, Leonard PLoS One Research Article BACKGROUND: Recent studies have demonstrated the association between increased concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and the incidence of myocardial infarction, heart failure, and mortality. However, most prognostic studies to date focus on the value of hs-cTnT in the elderly or general population. The value of hs-cTnT in symptomatic patients visiting the outpatient department remains unclear. The aim of this study was to investigate the prognostic value of hs-cTnT as a biomarker in patients with symptoms of chest discomfort suspected for coronary artery disease and to assess its additional value in combination with other risk stratification tools in predicting cardiac events. METHODS: We studied 1,088 patients (follow-up 2.2±0.8 years) with chest discomfort who underwent coronary calcium scoring and coronary CT-angiography. Traditional cardiovascular risk factors and concentrations of hs-cTnT, N-terminal pro-brain-type natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hsCRP) were assessed. Study endpoint was the occurrence of late coronary revascularization (>90 days), acute coronary syndrome, and cardiac mortality. RESULTS: Hs-cTnT was a significant predictor for the composite endpoint (highest quartile [Q4]>6.7 ng/L, HR 3.55; 95%CI 1.88–6.70; P<0.001). Survival analysis showed that hs-cTnT had significant predictive value on top of current risk stratification tools (Chi-square change P<0.01). In patients with hs-cTnT in Q4 versus <Q4, a 2- to 3-fold increase in cardiovascular risk was noticed, either when corrected for high or low Framingham risk score, coronary calcium scoring, or CT-angiography assessment (HR 3.11; 2.73; 2.47; respectively; all P<0.01). This was not the case for hsCRP and NT-proBNP. CONCLUSIONS: Hs-cTnT is a useful prognostic biomarker in patients with chest discomfort suspected for coronary artery disease. In addition, hs-cTnT was an independent predictor for cardiac events when corrected for cardiovascular risk profiling, calcium score and CT-angiography results. Public Library of Science 2012-04-25 /pmc/articles/PMC3338816/ /pubmed/22558116 http://dx.doi.org/10.1371/journal.pone.0035059 Text en Mingels et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Mingels, Alma M.
Joosen, Ivo A.
Versteylen, Mathijs O.
Laufer, Eduard M.
Winkens, Mark H.
Wildberger, Joachim E.
Van Dieijen-Visser, Marja P.
Hofstra, Leonard
High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort
title High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort
title_full High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort
title_fullStr High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort
title_full_unstemmed High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort
title_short High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort
title_sort high-sensitivity cardiac troponin t: risk stratification tool in patients with symptoms of chest discomfort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338816/
https://www.ncbi.nlm.nih.gov/pubmed/22558116
http://dx.doi.org/10.1371/journal.pone.0035059
work_keys_str_mv AT mingelsalmam highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort
AT joosenivoa highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort
AT versteylenmathijso highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort
AT laufereduardm highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort
AT winkensmarkh highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort
AT wildbergerjoachime highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort
AT vandieijenvissermarjap highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort
AT hofstraleonard highsensitivitycardiactroponintriskstratificationtoolinpatientswithsymptomsofchestdiscomfort